[
 {
  "title": "Type 1 Diabetes and Strategies to Thrive",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Pediatric endocrinologist specializing in helping people with type 1 diabetes discusses the best strategies to live and thrive with T1D, especially as it relates to diet and exercise. Many patients who control their blood sugar with high amounts of exogenous insulin are at a substantially higher risk than people who can control their blood sugar at lower levels of insulin. This concept has great implications for non-diabetics as well considering the increasing prevalence of diseases related to insulin resistance.",
  "content_length": 518,
  "content_tokens": 93,
  "embedding": []
 },
 {
  "title": "Increasing Prevalence of Type 1 Diabetes",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The increasing prevalence of type 1 diabetes and what we can do to help kids with this disease, and their families.",
  "content_length": 115,
  "content_tokens": 23,
  "embedding": []
 },
 {
  "title": "Pathophysiology of Type 1 Diabetes",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The pathophysiology of type 1 diabetes, the increase in prevalence, and the role of beta cells.",
  "content_length": 95,
  "content_tokens": 21,
  "embedding": []
 },
 {
  "title": "Body Weight and BMI in T1D Risk",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The role of body weight and BMI in the risk of developing T1D.",
  "content_length": 62,
  "content_tokens": 16,
  "embedding": []
 },
 {
  "title": "Genetics of T1D and Risk of Inheritance",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Genetics of T1D and the risk of inheritance.",
  "content_length": 44,
  "content_tokens": 12,
  "embedding": []
 },
 {
  "title": "Insulin and its Effects",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Insulin: the amazing story of its discovery, its effect on cellular metabolism and IGF-1, and why the hell it’s so expensive.",
  "content_length": 125,
  "content_tokens": 31,
  "embedding": []
 },
 {
  "title": "Diabetes Control and Complication Trial",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Diabetes Control and Complication Trial: blood glucose and the complications associated with diabetes.",
  "content_length": 102,
  "content_tokens": 17,
  "embedding": []
 },
 {
  "title": "Cognitive Impairment and Blood Glucose Levels",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Cognitive impairment, epigenetic changes, and other dangers associated with high, peak blood glucose, and big swings in blood glucose levels.",
  "content_length": 141,
  "content_tokens": 27,
  "embedding": []
 },
 {
  "title": "Depression, Anxiety, and T1D",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Depression, anxiety, and other challenges of living with T1D.",
  "content_length": 61,
  "content_tokens": 15,
  "embedding": []
 },
 {
  "title": "Managing Diabetes with Exercise",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Managing diabetes with exercise.",
  "content_length": 32,
  "content_tokens": 6,
  "embedding": []
 },
 {
  "title": "The Bernstein Method and Protein's Impact on Glucose and Insulin",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The Bernstein method, and protein’s impact on glucose and insulin.",
  "content_length": 66,
  "content_tokens": 15,
  "embedding": []
 },
 {
  "title": "Controlling T1D",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "What other tools are there for controlling T1D?",
  "content_length": 47,
  "content_tokens": 11,
  "embedding": []
 },
 {
  "title": "Ketogenic Diet and T1D",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Is the ketogenic diet appropriate for those with T1D?",
  "content_length": 53,
  "content_tokens": 13,
  "embedding": []
 },
 {
  "title": "Lessons for Non-Diabetic Population",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The most important lessons that can be applied by the non-diabetic population.",
  "content_length": 78,
  "content_tokens": 16,
  "embedding": []
 },
 {
  "title": "Optimizing Brain Health",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Alzheimer's disease risk factors, APOE, prevention strategies, and more.",
  "content_length": 72,
  "content_tokens": 17,
  "embedding": []
 },
 {
  "title": "Training Principles for Longevity",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Training principles for longevity.",
  "content_length": 34,
  "content_tokens": 5,
  "embedding": []
 },
 {
  "title": "Preventing Cardiovascular Disease",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The latest in diagnostic imaging, blood pressure, metabolic health, and more.",
  "content_length": 77,
  "content_tokens": 15,
  "embedding": []
 },
 {
  "title": "Pros and Cons of GLP-1 Weight Loss Drugs and Metformin",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent.",
  "content_length": 81,
  "content_tokens": 23,
  "embedding": []
 },
 {
  "title": "Cell Therapy and Gene Therapy",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The history of the cell, cell therapy, gene therapy, and more.",
  "content_length": 62,
  "content_tokens": 15,
  "embedding": []
 },
 {
  "title": "Type 1 Diabetes Management",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Best strategies to live and thrive with Type 1 Diabetes, especially as it relates to diet and exercise. Many patients who control their blood sugar with high amounts of exogenous insulin are at a substantially higher risk than people who can control their blood sugar at lower levels of insulin. This concept has great implications for non-diabetics as well considering the increasing prevalence of diseases related to insulin resistance.",
  "content_length": 438,
  "content_tokens": 78,
  "embedding": []
 },
 {
  "title": "Insulin and Diabetes",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Insulin: the amazing story of its discovery, its effect on cellular metabolism and IGF-1, and why the hell it’s so expensive. Diabetes Control and Complication Trial: blood glucose and the complications associated with diabetes.",
  "content_length": 228,
  "content_tokens": 47,
  "embedding": []
 },
 {
  "title": "Mental Health and Type 1 Diabetes",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Depression, anxiety, and other challenges of living with Type 1 Diabetes.",
  "content_length": 73,
  "content_tokens": 15,
  "embedding": []
 },
 {
  "title": "Exercise and Diabetes Management",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Managing diabetes with exercise. The Bernstein method, and protein’s impact on glucose and insulin.",
  "content_length": 99,
  "content_tokens": 21,
  "embedding": []
 },
 {
  "title": "Ketogenic Diet and Type 1 Diabetes",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Is the ketogenic diet appropriate for those with Type 1 Diabetes?",
  "content_length": 65,
  "content_tokens": 13,
  "embedding": []
 },
 {
  "title": "Lessons for Non-Diabetic Population",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The most important lessons that can be applied by the non-diabetic population.",
  "content_length": 78,
  "content_tokens": 16,
  "embedding": []
 },
 {
  "title": "Pathophysiology of Type 1 Diabetes",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The pathophysiology of type 1 diabetes, the increase in prevalence, and the role of beta cells.",
  "content_length": 95,
  "content_tokens": 21,
  "embedding": []
 },
 {
  "title": "Autoimmunity and Type 1 Diabetes",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "When antigens are dumped off and provoke autoimmunity, a progressive autoimmunity can occur, leading to the loss of beta cells over time. There is no single virus that can be conclusively ascribed to autoimmunity and type 1 diabetes. The incidence of type 1 diabetes has doubled since 1960, possibly due to environmental factors such as obesity, exposure to new viruses, or improved diagnostic methods.",
  "content_length": 402,
  "content_tokens": 85,
  "embedding": []
 },
 {
  "title": "Diagnosing Type 1 Diabetes in Children and Adults",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Greater awareness has led to earlier diagnosis of type 1 diabetes in children, sometimes as early as 6 months. However, without checking the serum glucose, life threatening diabetic ketoacidosis and new onset type 1 diabetes might go unnoticed. Children have a more aggressive onset of the disease due to a lack of reserve of beta cells, making the condition life threatening quicker. Adults have a greater reserve of beta cells, so their onset takes longer and progresses slowly, making diagnosis difficult. Misdiagnosis often occurs, with people being diagnosed with type 2 diabetes when they actually have type 1.",
  "content_length": 616,
  "content_tokens": 118,
  "embedding": []
 },
 {
  "title": "Role of B Cells in Type 1 Diabetes",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Beta cells make very unique things, and when destroyed, they begin to dump them out, triggering both B and T cell responses. Antibodies can be tested for in the serum of people with type 1 diabetes, and they make unique antibodies against insulin and GAD, glutamic acid decarboxylase, as well as a protein, tyrosine phosphatase called ICA 512. These antibodies are commonly used in the diagnosis of type 1 diabetes, which is believed to be a T cell disease. However, antibodies are made by B cells, so there must be some contribution. A clinical trial using Rituximab, which alters B cell function, was able to delay the course of type 1 diabetes.",
  "content_length": 647,
  "content_tokens": 146,
  "embedding": []
 },
 {
  "title": "Body Weight, BMI, and Risk of Type 1 Diabetes",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "There is some evidence that a higher BMI could predispose kids to type 1 diabetes. This implies that the Standard American Diet (SAD) may be predisposing the population in aggregate towards more type 1 diabetes.",
  "content_length": 211,
  "content_tokens": 42,
  "embedding": []
 },
 {
  "title": "Genetics of Type 1 Diabetes and Risk of Inheritance",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Certain HLA alleles are quite common in the human population, such as HLA-DR3 and HLA-DR4, and when combined, they increase the odds of having a child with type 1 diabetes. The risk of a child getting type 1 diabetes if one of their parents has it is statistically a 10x increase. However, since type 1 diabetes is 1 in 300 for the general population, a 10x increase only brings it to 1 in 30.",
  "content_length": 393,
  "content_tokens": 94,
  "embedding": []
 },
 {
  "title": "Hemoglobin A1c and Type 2 Diabetes Diagnosis",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Hemoglobin A1c is a way to understand the average blood glucose a person has. It measures the amount of glycosylation, or how much glucose is sticking to hemoglobin. Today, a diagnosis of type 2 diabetes is made solely on the hemoglobin A1c being greater than 6.5%. It no longer relies on the insulin or glucose level during an oral glucose challenge.",
  "content_length": 351,
  "content_tokens": 80,
  "embedding": []
 },
 {
  "title": "Insulin Discovery and Its Effect on Cellular Metabolism",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Insulin is a key factor in regulating virtually every cell in the body. It recognizes whether a cell is in a state of feast or famine. In a feast, it takes the nutrients and parks them in the cell. In a famine, it will mobilize some nutrients and make them available to keep the organism alive. Insulin is a master regulator of your state of metabolism.",
  "content_length": 353,
  "content_tokens": 75,
  "embedding": []
 },
 {
  "title": "Insulin and IGF",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "When insulin goes up, free IGF-1 goes up. This is because insulin drives down the IGF binding proteins. Insulin and IGF-1 one really are intensely overlapping in the way they work.",
  "content_length": 180,
  "content_tokens": 40,
  "embedding": []
 },
 {
  "title": "The Cost of Recombinant Insulin",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Recombinant insulin, which used to be cheap, now costs $300-$400 for 1,000 units, a month's supply.",
  "content_length": 99,
  "content_tokens": 28,
  "embedding": []
 },
 {
  "title": "Insulin Pricing",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The price of insulin is significantly higher in the United States compared to other countries, such as Spain. This is largely due to the federal government's willingness to pay whatever the sellers charge, which has prevented the price from being driven down. This is particularly problematic for individuals on the margins of society who want modern care and are willing to pay for it, but cannot afford the high cost of insulin in the U.S.",
  "content_length": 441,
  "content_tokens": 84,
  "embedding": []
 },
 {
  "title": "Diabetes Complications",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Diabetes can lead to a range of complications, including amputations, blindness, and kidney problems. These complications are caused by damage to the vascular endothelium, altered healing, and diabetic neuropathy. High glucose levels can alter the epithelia of the kidney that's involved in filtering blood and making urine. Diabetic neuropathy can cause nerves to lose their responsiveness when exposed to high glucose levels. Abnormal healing can result in diabetic wounds that fail to improve with antibiotics and may ultimately require amputation.",
  "content_length": 551,
  "content_tokens": 102,
  "embedding": []
 },
 {
  "title": "Diabetes Control and Complication Trial (DCCT)",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The DCCT set out to test whether tight control of blood glucose confers protection against diabetes complications. The results, published in 1993, showed that as average blood glucose increases, so do microvascular complications. However, controlling blood sugar in people with type 1 diabetes is challenging due to the volatility in blood glucose. Factors such as stress, sleep quality, and exercise can all impact blood glucose levels.",
  "content_length": 437,
  "content_tokens": 81,
  "embedding": []
 },
 {
  "title": "Side Effects of Tight Control of Blood Glucose",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Tight control of blood glucose can lead to hypoglycemic events and weight gain. Weight gain is a common problem in type 1 diabetes, often resulting from the need to consume refined carbohydrates to raise blood glucose levels when they are low due to high insulin levels. This can lead to uncontrollable weight gain and poor cardiovascular outcomes.",
  "content_length": 348,
  "content_tokens": 65,
  "embedding": []
 },
 {
  "title": "Cognitive Impairment and Epigenetic Changes",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Exposure to high blood glucose levels or variability in blood glucose levels can lead to cognitive impairment and epigenetic changes. Short exposures to high blood sugar levels can change gene expression in cells, potentially contributing to diabetes complications.",
  "content_length": 265,
  "content_tokens": 43,
  "embedding": []
 },
 {
  "title": "Mental Health Challenges in Type 1 Diabetes",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Living with type 1 diabetes can lead to a high cognitive load, anxiety, and depression. The constant need to monitor and manage blood glucose levels can be overwhelming and interfere with daily life. This is reflected in the high scores on the diabetes distress scale, which measures the impact of diabetes on a person's life. The medical establishment often reinforces feelings of guilt and shame in patients who struggle to manage their condition.",
  "content_length": 449,
  "content_tokens": 81,
  "embedding": []
 },
 {
  "title": "Continuous Glucose Monitor",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "In 2007, the original model of the continuous glucose monitor (CGM) made by Dexcom was introduced. However, this first device was frustrating for patients because they didn’t really know what do with the information. Doctors involved in treating these patients didn’t have much advice other than to badger them to do a better job with managing their insulin doses and carbohydrate feedings.",
  "content_length": 390,
  "content_tokens": 79,
  "embedding": []
 },
 {
  "title": "Managing Diabetes with Exercise",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Exercise can help people control their diabetes. Part of the mechanism is via the insulin-independent glucose uptake into skeletal muscle via AMP kinase. An enzyme that is sensing the energy status of the cell. If you alter the energy status of the cell through a tremendous amount of work (exercise), it signals the GLUT4 to translocate to the membrane of the skeletal muscle. So now you get insulin-independent glucose uptake into skeletal muscle.",
  "content_length": 449,
  "content_tokens": 91,
  "embedding": []
 },
 {
  "title": "The Bernstein Method",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The Bernstein method helps both those with type 1 and type 2 diabetes. It figured out that if you avoided carbohydrates and if you give medium and long acting insulin to cover protein and fat and basal metabolic requirements, that you could get blood glucoses very, very close to normal. He typically prescribes a low carb, high protein diet. It’s not low carb, high fat, it’s not ketogenic.",
  "content_length": 391,
  "content_tokens": 86,
  "embedding": []
 },
 {
  "title": "Controlling Type 1 Diabetes",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "First and foremost, a continuous glucose monitor (CGM) by Dexcom is essential. Next, it’s important to be informed. Bernstein’s book: Dr. Bernstein’s Diabetes Solution: The Complete Guide to Achieving Normal Blood Sugars. Book by Adam Brown: Bright Spots & Landmines: The Diabetes Guide I Wish Someone Had Handed Me.",
  "content_length": 316,
  "content_tokens": 80,
  "embedding": []
 },
 {
  "title": "Ketogenic Diet and Type 1 Diabetes",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "People with T1D that are trying to get into nutritional ketosis have a few unique problems: Diabetic ketoacidosis (DKA), Euglycemic DKA, Nutritional ketosis and hypoglycemic awareness.",
  "content_length": 184,
  "content_tokens": 46,
  "embedding": []
 },
 {
  "title": "Lessons for Non-Diabetic Population",
  "date": "February 18, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Hyperinsulinemia leads to cardiovascular disease. There’s something about the Standard American Diet that’s making us sick. And ultimately we will be at risk for cardiovascular disease. Lessons from observing treatment options for type 2 diabetics. Two types of treatments: Metformin, which lowers blood glucose. Drugs that raise insulin (to indirectly suppress blood glucose).",
  "content_length": 377,
  "content_tokens": 76,
  "embedding": []
 }
]